Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole - PubMed (original) (raw)

Clinical Trial

Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole

Kari Raaska et al. Clin Pharmacol Ther. 2002 Oct.

Abstract

Objective: Our objective was to examine the effects of itraconazole on the pharmacokinetics and cortisol-suppressant activity of budesonide administered by inhalation.

Methods: In a randomized, double-blind, 2-phase crossover study, 10 healthy subjects took 200 mg itraconazole or placebo orally once a day for 5 days. On day 5, 1 hour after the last dose of itraconazole or placebo, 1000 microg budesonide was administered by inhalation. Plasma budesonide and cortisol concentrations were measured up to 23 hours.

Results: Itraconazole increased the mean total area under the plasma concentration-time curve of inhaled budesonide 4.2-fold (range, 1.7-fold to 9.8-fold; P <.01) and the peak plasma concentration 1.6-fold (P <.01) compared with placebo. The mean terminal half-life of budesonide was prolonged from 1.6 to 6.2 hours (ie, 3.7-fold; range, 1.5-fold to 9.3-fold; P <.001) by itraconazole. The suppression of cortisol production after inhalation of budesonide was significantly increased by itraconazole as compared with placebo, as shown by a 43% reduction in the area under the plasma cortisol concentration-time curve from 0.5 to 10 hours (P <.001) and a 12% decrease in the cortisol concentration measured 23 hours after administration of budesonide, at 8 am (P <.05).

Conclusions: Itraconazole markedly increased systemic exposure to inhaled budesonide, probably by inhibiting the cytochrome P4503A4-mediated metabolism of budesonide during both the first-pass and the elimination phases. This interaction resulted in enhanced systemic effects of budesonide, as shown by suppression of cortisol production. Long-term coadministration of budesonide and a potent CYP3A4 inhibitor may be associated with an increased risk of adverse effects of budesonide.

PubMed Disclaimer

Cited by

Budesonide/formoterol: in chronic obstructive pulmonary disease.
Reynolds NA, Perry CM, Keating GM. Reynolds NA, et al. Drugs. 2004;64(4):431-41; discussion 433-4. doi: 10.2165/00003495-200464040-00006. Drugs. 2004. PMID: 14969576 Review.
Effect of coadministered ketoconazole, a strong cytochrome P450 3A4 enzyme inhibitor, on the pharmacokinetics of ciclesonide and its active metabolite desisobutyryl-ciclesonide.
Böhmer GM, Drollmann A, Gleiter CH, Nave R. Böhmer GM, et al. Clin Pharmacokinet. 2008;47(5):343-9. doi: 10.2165/00003088-200847050-00005. Clin Pharmacokinet. 2008. PMID: 18399715 Clinical Trial.
Comparison of the effects of itraconazole and prednisolone on _fibroblast growth factor_-2 gene expression and clinical manifestations in patients with persistent severe asthma.
Manafi Varkiani M, Mirsadraee M, Anhaee Nasseri Z, Khakzad M, Ghaffari S, Rabbani Nia T. Manafi Varkiani M, et al. Curr Med Mycol. 2023 Jun;9(2):1-9. doi: 10.22034/CMM.2023.345036.1401. Curr Med Mycol. 2023. PMID: 38375524 Free PMC article.
Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match.
Ponce DM, Gonzales A, Lubin M, Castro-Malaspina H, Giralt S, Goldberg JD, Hanash AM, Jakubowski A, Jenq R, Papadopoulos EB, Perales MA, van den Brink MR, Young JW, Boulad F, O'Reilly RJ, Prockop S, Small TN, Scaradavou A, Kernan NA, Stevens CE, Barker JN. Ponce DM, et al. Biol Blood Marrow Transplant. 2013 Jun;19(6):904-11. doi: 10.1016/j.bbmt.2013.02.008. Epub 2013 Feb 14. Biol Blood Marrow Transplant. 2013. PMID: 23416854 Free PMC article.
Sensitization to Aspergillus species is associated with frequent exacerbations in severe asthma.
Goh KJ, Yii ACA, Lapperre TS, Chan AK, Chew FT, Chotirmall SH, Koh MS. Goh KJ, et al. J Asthma Allergy. 2017 Apr 21;10:131-140. doi: 10.2147/JAA.S130459. eCollection 2017. J Asthma Allergy. 2017. PMID: 28461762 Free PMC article.

Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole - PubMed (original) (raw)